103 related articles for article (PubMed ID: 21263092)
1. Treatment of low-risk gestational trophoblastic neoplasia.
Aghajanian C
J Clin Oncol; 2011 Mar; 29(7):786-8. PubMed ID: 21263092
[No Abstract] [Full Text] [Related]
2. Comparison of pulse methotrexate and pulse dactinomycin in the treatment of low-risk gestational trophoblastic neoplasia.
Gilani MM; Yarandi F; Eftekhar Z; Hanjani P
Aust N Z J Obstet Gynaecol; 2005 Apr; 45(2):161-4. PubMed ID: 15760322
[TBL] [Abstract][Full Text] [Related]
3. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia: a Gynecologic Oncology Group study.
Covens A; Filiaci VL; Burger RA; Osborne R; Chen MD;
Cancer; 2006 Sep; 107(6):1280-6. PubMed ID: 16900525
[TBL] [Abstract][Full Text] [Related]
4. Treatment for low-risk gestational trophoblastic disease: comparison of single-agent methotrexate, dactinomycin and combination regimens.
AbrĂ£o RA; de Andrade JM; Tiezzi DG; Marana HR; Candido dos Reis FJ; Clagnan WS
Gynecol Oncol; 2008 Jan; 108(1):149-53. PubMed ID: 17931696
[TBL] [Abstract][Full Text] [Related]
5. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole.
Lurain JR
Am J Obstet Gynecol; 2010 Dec; 203(6):531-9. PubMed ID: 20728069
[TBL] [Abstract][Full Text] [Related]
6. [Etopside, methotrexate, kengshengmycin/etopside, cisplatin chemotherapy for chemorefractory gestational trophoblastic tumour].
Xiang Y; Wan XR; Sun ZJ; Yang XY
Zhonghua Fu Chan Ke Za Zhi; 2005 Feb; 40(2):79-82. PubMed ID: 15840283
[TBL] [Abstract][Full Text] [Related]
7. Single-agent pulse dactinomycin has only modest activity for methotrexate-resistant gestational trophoblastic neoplasia.
Chen LM; Lengyel ER; Bethan Powell C
Gynecol Oncol; 2004 Jul; 94(1):204-7. PubMed ID: 15262143
[TBL] [Abstract][Full Text] [Related]
8. Phase III trial of weekly methotrexate or pulsed dactinomycin for low-risk gestational trophoblastic neoplasia: a gynecologic oncology group study.
Osborne RJ; Filiaci V; Schink JC; Mannel RS; Alvarez Secord A; Kelley JL; Provencher D; Scott Miller D; Covens AL; Lage JM
J Clin Oncol; 2011 Mar; 29(7):825-31. PubMed ID: 21263100
[TBL] [Abstract][Full Text] [Related]
9. Treatment of metastatic gestational choriocarcinoma with oral methotrexate in a combat environment.
Farley JH; Heathcock RB; Branch W; Larsen W; Homas D
Obstet Gynecol; 2005 May; 105(5 Pt 2):1250-4. PubMed ID: 15863599
[TBL] [Abstract][Full Text] [Related]
10. High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
Soper JT; Spillman M; Sampson JH; Kirkpatrick JP; Wolf JK; Clarke-Pearson DL
Gynecol Oncol; 2007 Mar; 104(3):691-4. PubMed ID: 17137617
[TBL] [Abstract][Full Text] [Related]
11. Secondary chemotherapy for high-risk gestational trophoblastic neoplasia.
Lurain JR; Nejad B
Gynecol Oncol; 2005 May; 97(2):618-23. PubMed ID: 15863169
[TBL] [Abstract][Full Text] [Related]
12. EMA/EP chemotherapy for chemorefractory gestational trophoblastic tumor.
Xiang Y; Sun Z; Wan X; Yang X
J Reprod Med; 2004 Jun; 49(6):443-6. PubMed ID: 15283051
[TBL] [Abstract][Full Text] [Related]
13. Management of drug resistant gestational trophoblastic neoplasia.
Patel SM; Desai A
J Reprod Med; 2010; 55(7-8):296-300. PubMed ID: 20795341
[TBL] [Abstract][Full Text] [Related]
14. Comment on single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Mahajan NN; Soni RN; Mahajan KN
Am J Obstet Gynecol; 2007 Sep; 197(3):325; author reply 325. PubMed ID: 17826442
[No Abstract] [Full Text] [Related]
15. Role of surgery in the management of high-risk gestational trophoblastic neoplasia.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):773-6. PubMed ID: 17086805
[TBL] [Abstract][Full Text] [Related]
16. Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy.
Lurain JR; Singh DK; Schink JC
J Reprod Med; 2006 Oct; 51(10):767-72. PubMed ID: 17086804
[TBL] [Abstract][Full Text] [Related]
17. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia.
Kang WD; Choi HS; Kim SM
Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479
[TBL] [Abstract][Full Text] [Related]
18. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia.
Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY
Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109
[TBL] [Abstract][Full Text] [Related]
19. Gestational trophoblastic neoplasia management: an update.
Ngan S; Seckl MJ
Curr Opin Oncol; 2007 Sep; 19(5):486-91. PubMed ID: 17762576
[TBL] [Abstract][Full Text] [Related]
20. Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia.
Lurain JR
Am J Obstet Gynecol; 2011 Jan; 204(1):11-8. PubMed ID: 20739008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]